Congress Passes Emergency Supplemental Funding to Combat Coronavirus
Washington, D.C. - March 6, 2020 - Yesterday, Congress passed theCoronavirus Preparedness and Response Supplemental Appropriations Act
This bipartisan agreement provides $8.3 billion in emergency, supplemental funding to combat the spread of the
virus, including funding for vaccine development, support for state and local governments, and assistance for affected
small businesses. This bipartisan package includes:
- $61 million for the Food and Drug Administration to facilitate the development and review, both pre-market and
post-market, of medical countermeasures, devices, therapies, and vaccines to combat the coronavirus.
- $1 billion in loan subsidies made available to help small businesses impacted by financial losses as a result of
- $2.2 billion for the Centers for Disease Control and Prevention to support federal, state, and local public health
agencies to prevent, prepare for, and respond to the coronavirus.
- More than $3 billion for research and development of vaccines, therapeutics, and diagnostics to prevent or treat
the effects of the virus.
- Nearly $1 billion for procurement of pharmaceuticals and medical supplies, to support healthcare preparedness and
Community Health Centers, and to improve medical surge capacity.
the risk of COVID-19 in the U.S. is low and recommends taking every day preventative actions to avoid the flu.